Ocugen Ownership | Who Owns Ocugen?
Ocugen Ownership Summary
Ocugen is owned by 35.04% institutional investors, 1.68% insiders, and 63.28% retail investors. Blackrock is the largest institutional shareholder, holding 6.97% of OCGN shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 4.12% of its assets in Ocugen shares.
OCGN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Ocugen | 35.04% | 1.68% | 63.28% |
| Sector | Healthcare Stocks | 35.56% | 12.08% | 52.36% |
| Industry | Biotech Stocks | 35.43% | 12.01% | 52.56% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 17.92M | 6.97% | $27.78M |
| Vanguard group | 16.48M | 5.42% | $22.24M |
| Millennium management | 13.73M | 4.39% | $24.85M |
| State street | 9.67M | 3.10% | $17.50M |
| Marshall wace, llp | 8.05M | 2.58% | $14.57M |
| Blackrock funding, inc. /de | 7.30M | 2.34% | $13.22M |
| Ubs group | 7.28M | 2.33% | $13.18M |
| Rtw investments, lp | 6.67M | 2.13% | $12.07M |
| Geode capital management | 4.23M | 1.35% | $7.65M |
| Ikarian capital | 3.96M | 1.27% | $7.17M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ikarian capital | 3.96M | 0.58% | $7.17M |
| Gmt capital | 3.51M | 0.29% | $6.34M |
| Scientech research | 188.53K | 0.28% | $341.23K |
| Cannon global investment management | 70.00K | 0.25% | $126.70K |
| Quantessence capital | 25.95K | 0.23% | $46.97K |
| Hennion & walsh asset management | 2.83M | 0.12% | $4.33M |
| Rtw investments, lp | 6.67M | 0.12% | $12.07M |
| Caitong asset management | 197.65K | 0.07% | $357.74K |
| Diadema partners lp | 200.00K | 0.06% | $362.00K |
| Catalyst funds management pty | 180.60K | 0.06% | $326.89K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 17.92M | 0.00% | 14.12M |
| Millennium management | 13.73M | 0.01% | 8.33M |
| Rtw investments, lp | 6.67M | 0.12% | 6.67M |
| State street | 9.67M | 0.00% | 5.69M |
| Marshall wace, llp | 8.05M | 0.01% | 5.52M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Altium capital management lp | - | - | -2.35M |
| Renaissance | - | - | -1.70M |
| Cubist systematic strategies | 78.83K | 0.00% | -1.59M |
| Goldman sachs group | 1.13M | 0.00% | -1.18M |
| Rinkey investments | - | - | -1.03M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Rtw investments, lp | 6.67M | 0.12% | 6.67M | $12.07M |
| Ikarian capital | 3.96M | 0.58% | 3.96M | $7.17M |
| Qube research | 3.77M | 0.01% | 3.77M | $6.83M |
| Vanguard fiduciary trust | 2.00M | 0.00% | 2.00M | $3.62M |
| Boothbay fund management | 1.10M | 0.03% | 1.10M | $1.99M |
Sold Out
| Holder | Change |
|---|---|
| Psi advisors | -1.00 |
| Chris bulman | -13.00 |
| Nbt bank n a /ny | -50.00 |
| Huntington national bank | -100.00 |
| Strategic investment solutions, inc. /il | -125.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 143 | 23.28% | 109,433,421 | 79.84% | 35 | 8.74% | 87 | 42.62% | 22 | 10.00% |
| Dec 31, 2025 | 52 | -49.51% | 36,188,300 | -21.17% | 11 | 4.82% | 25 | -34.21% | 9 | -75.68% |
| Sep 30, 2025 | 35 | -67.89% | 17,195,153 | -66.71% | 5 | 1.88% | 9 | -85.25% | 11 | -54.17% |
| Jun 30, 2025 | 109 | -5.22% | 51,825,743 | -32.44% | 17 | 2.57% | 62 | 16.98% | 23 | -25.81% |
| Mar 31, 2025 | 115 | -3.36% | 76,711,171 | 7.31% | 26 | 4.33% | 54 | 1.89% | 30 | -6.25% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 13.93M | 4.12% | -310.32K |
| Vanguard US Total Market Shares ETF | 9.07M | 3.11% | - |
| Vanguard Total Stock Mkt Idx Inv | 10.18M | 3.01% | 375.10K |
| SPDR® S&P Biotech ETF | 8.70M | 2.99% | 123.82K |
| iShares Russell 2000 ETF | 8.77M | 2.59% | 52.07K |
| Vanguard Institutional Extnd Mkt Idx Tr | 3.88M | 1.15% | 158.11K |
| Fidelity Small Cap Index | 2.95M | 1.01% | - |
| Russell 2000 Index Non-Lendable Fund | 2.25M | 0.66% | 2.25M |
| Russell 2000 Equity Index Fund B | 2.25M | 0.66% | 2.25M |
| iShares Russell 2000 Growth ETF | 2.20M | 0.65% | -8.47K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Johnson-Greene Treerita Essalima | Chief Financial Officer | Buy | $25.83K |
| Nov 26, 2024 | Fernandes Prabhavathi | - | Buy | $9.10K |
| Nov 22, 2024 | Castillo Kirsten | - | Buy | $22.85K |
| Jun 14, 2023 | Zhang Junge | - | Buy | $100.00K |
| Feb 16, 2023 | Musunuri Shankar | Chief Executive Officer | Sell | $108.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | 1 | - |
| 2026 Q1 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | 2 | - |
OCGN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools